Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Spectranetics Corp.

Aug 2008
The ThromboAblation in Acute Myo-cardial Infarction trial has begun enrolling participants. The 200-patient randomized trial, to be performed by Spectranetics Corp. of Colorado Springs, Colo., will test the usefulness of excimer lasers in treating people with a large thrombus burden presenting with ST wave elevation myocardial infarction.

Biophotonicsexcimer lasersNews & FeaturesSpectranetics Corp.lasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.